David is a strategic, life sciences, and technology transactions and data privacy counsel based in Ropes & Gray’s Shanghai office. He regularly advises clients in the life sciences and technology industries in strategic collaborations, intellectual property transactions, general commercial matters, and data monetization, protection and privacy matters. He also frequently advises private equity funds and other financial institutions in investment and financing transactions, mergers and acquisitions, and foreign direct investments in the APAC region. He often counsels clients on protecting and leveraging their data, patents, trade secrets, copyrights, trademarks, and other intellectual property rights in China.
David specializes in advising pharmaceutical, biotech, digital health, and medical device companies on their transactions encompassing the entire value chain, including on early-stage collaboration on drug discovery, in-licensing and out-licensing of drug candidates, CMO and CRO arrangements, supply, distribution, promotion, and cross-industry digital health initiatives.
David also regularly advises mobile app, mobile gaming, digital media, and data-driven companies on their transactions involving mobile app, mobile game, and content development and distribution and data sharing.
He is a California native, has lived and practiced in China since 2009, and is fluent in Chinese (Mandarin).